Concepedia

K. Dimick

KD

Statistics

Publications

2

Citations

84

H-Index

2

Active since

2007

Affiliations

Sarah Cannon(Current)

K. Dimick is an author at Sarah Cannon specializing in cancer immunology, cancer immunotherapy, and immune checkpoint combination therapy.

Publications per year

2007–2018

2

Publications

2

A phase IB safety and pharmacokinetic (PK) study of recombinant human Apo2L/TRAIL in combination with rituximab in patients with low-grade non-Hodgkin lymphoma

Lorrin Yee, Michelle A. Fanale, K. Dimick et al. · Journal of Clinical Oncology · 2007 · 65 citations

, , +17

MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

Ian Chau, Georg Martin Haag, Osama E. Rahma et al. · Annals of Oncology · 2018 · 19 citations · Full text

, , +16

1–2 of 2